abstract |
"GLP-1 COMPOUND, GLP-1 RECEIVER STIMULATION METHOD IN AN INDIVIDUAL REQUIRING SUCH STIMULATION, AND USE OF A GLP-1 COMPOUND". Glucagon-like peptide-1 (GLP-1) compounds having modifications at one or more of the following positions are described: 7, 8, 12, 16, 18, 19, 20, 22, 25, 27, 30, 33, and 37. Methods of treating an individual in need of GLP-1 receptor stimulation using these GLP-1 compounds are also described. |